Last reviewed · How we verify
pMDI standard actuator
At a glance
| Generic name | pMDI standard actuator |
|---|---|
| Sponsor | Chiesi Farmaceutici S.p.A. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study in Adult Patients With Moderate to Severe Asthma (PHASE3)
- Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD Patients (PHASE1)
- Foster With or Without Charcoal Block or Aerochamber Plus (PHASE1)
- Study Comparing Foster Efficacy Maintenance and Reliever Versus Foster Maintenance + Salbutamol Reliever in Asthmatics (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |